Event JSON
{
"id": "bbdc8e3fbc3b27fcf98f8b432e74b2a3da727ad853bbfdd5c5a896f1928a33bb",
"pubkey": "f261e77ed38c5a7c6cf34564b89b26bc002380ab3b4c2cab919e028030c393e7",
"created_at": 1732625443,
"kind": 1,
"tags": [
[
"r",
"https://www.foxnews.com/health/ozempic-wegovy-covered-medicare-medicaid-biden-admin-proposal-anti-obesity-glp1-drugs"
],
[
"subject",
"Ozempic, Wegovy covered by Medicare and Medicaid under Biden admin proposal for anti-obesity GLP-1 drugs"
],
[
"published_at",
"1732624853"
],
[
"image",
"https://a57.foxnews.com/static.foxnews.com/foxnews.com/content/uploads/2024/11/60/60/wegovy.jpg?ve=1\u0026tl=1"
],
[
"p",
"f261e77ed38c5a7c6cf34564b89b26bc002380ab3b4c2cab919e028030c393e7",
"wss://articles.layer3.news"
],
[
"imeta",
"url https://a57.foxnews.com/static.foxnews.com/foxnews.com/content/uploads/2024/11/60/60/wegovy.jpg?ve=1\u0026tl=1"
],
[
"t",
"other:perspective"
],
[
"summary",
"The proposal aims to increase access to these medications for an estimated 3.4 million Americans with Medicare and 4 million adult Medicaid enrollees, reducing out-of-pocket costs by up to 95%. The drugs, which slow down digestion, are commonly prescribed for type 2 diabetes and obesity, and have been shown to reduce the risk of related comorbidities such as diabetes, cardiovascular disease, and some cancers."
]
],
"content": "nostr:nprofile1qyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq7fs7wlkn33d8cm8ng4jt3xexhsqz8q9t8dxze2u3ncpgqvxrj0ns8zan0k\nhttps://a57.foxnews.com/static.foxnews.com/foxnews.com/content/uploads/2024/11/60/60/wegovy.jpg?ve=1\u0026tl=1\nThe Biden administration is looking to expand access to anti-obesity GLP-1 drugs like Ozempic and Wegovy for people who have Medicare and Medicaid.\nhttps://www.foxnews.com/health/ozempic-wegovy-covered-medicare-medicaid-biden-admin-proposal-anti-obesity-glp1-drugs",
"sig": "d0c9037ce5de102fa1d7b0d4c0537587e128eace63be0bf2c053548258619c76a2470cadedfaccd4f4e9f5caf228711b22dd39c2d91227540df6d4098242a2c2"
}
